|
|
|
Insider
Information: |
Bhavnagri Veer |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
556,049 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
556,049 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-03-14 |
556,049 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
31 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
360,455 |
|
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-08-03 |
4 |
AS |
$36.46 |
$1,164,121 |
D/D |
(31,553) |
353,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-08-03 |
4 |
OE |
$2.27 |
$56,750 |
D/D |
25,000 |
385,455 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-09-01 |
4 |
OE |
$2.27 |
$56,750 |
D/D |
25,000 |
378,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-09-01 |
4 |
AS |
$35.35 |
$883,966 |
D/D |
(25,000) |
353,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-10-01 |
4 |
AS |
$36.21 |
$912,913 |
D/D |
(25,000) |
353,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-10-01 |
4 |
OE |
$2.27 |
$56,750 |
D/D |
25,000 |
378,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-10-06 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
353,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-10-06 |
4 |
OE |
$2.27 |
$22,700 |
D/D |
10,000 |
363,902 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2020-12-17 |
4 |
OE |
$2.27 |
$116,905 |
D/D |
51,500 |
405,402 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-03-15 |
4 |
AS |
$37.79 |
$630,798 |
D/D |
(16,623) |
399,151 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-03-15 |
4 |
OE |
$2.27 |
$22,700 |
D/D |
10,000 |
415,774 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,202 |
421,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-04-15 |
4 |
AS |
$32.01 |
$320,517 |
D/D |
(10,000) |
421,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-04-15 |
4 |
OE |
$2.27 |
$22,700 |
D/D |
10,000 |
431,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-05-17 |
4 |
AS |
$28.30 |
$141,476 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-05-17 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-05-18 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-05-18 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-07-15 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-07-15 |
4 |
AS |
$21.55 |
$107,753 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-08-16 |
4 |
AS |
$21.00 |
$104,994 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-08-16 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-09-15 |
4 |
AS |
$24.77 |
$123,845 |
D/D |
(5,000) |
421,669 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
General Counsel |
|
2021-09-15 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,669 |
0 |
- |
|
31 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|